PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
2B70.DE vs. NDAQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

2B70.DE vs. NDAQ

Last updated Jun 5, 2026

2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) is Health & Biotech Equities fund tracking the Nasdaq Biotechnology, while NDAQ (Nasdaq, Inc.) is a stock. Over the past 5 years, 2B70.DE returned 5.68%/yr vs 11.80%/yr for NDAQ. At a 0.25 correlation, their price movements are largely independent.

Performance

2B70.DE vs. NDAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Nasdaq, Inc. (NDAQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

2B70.DE is traded in EUR, while NDAQ is traded in USD. To make them comparable, the NDAQ values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, 2B70.DE achieves a 4.53% return, which is significantly higher than NDAQ's -7.61% return.

2B70.DE

1D
3.29%
1M
1.98%
YTD
4.53%
6M
3.42%
1Y
39.14%
3Y*
10.00%
5Y*
5.68%
10Y*
—

NDAQ

1D
1.75%
1M
0.04%
YTD
-7.61%
6M
-1.17%
1Y
4.95%
3Y*
14.95%
5Y*
11.80%
10Y*
16.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

2B70.DE vs. NDAQ - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF		4.53%18.62%4.60%2.56%-6.29%7.59%14.52%30.18%-7.35%2.65%
NDAQ
Nasdaq, Inc.		-7.61%12.09%43.75%-6.55%-5.69%72.10%15.61%36.90%13.29%-1.46%

Correlation

The correlation between 2B70.DE and NDAQ is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Nov 24, 2017

0.25

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares Nasdaq US Biotechnology UCITS ETF

Nasdaq, Inc.

Often compared with 2B70.DE:
2B70.DE vs. QDVG.DE2B70.DE vs. SLMC.DE2B70.DE vs. PFE2B70.DE vs. IBB2B70.DE vs. SPY2B70.DE vs. SHY2B70.DE vs. ARKG
Often compared with NDAQ:
NDAQ vs. QQQNDAQ vs. TQQQNDAQ vs. ICENDAQ vs. VOONDAQ vs. IOONDAQ vs. CBOENDAQ vs. MSCI

Return for Risk

2B70.DE vs. NDAQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
2B70.DE
2B70.DE Risk / Return Rank: 7171
Overall Rank
2B70.DE Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
2B70.DE Sortino Ratio Rank: 6363
Sortino Ratio Rank
2B70.DE Omega Ratio Rank: 5656
Omega Ratio Rank
2B70.DE Calmar Ratio Rank: 9292
Calmar Ratio Rank
2B70.DE Martin Ratio Rank: 8484
Martin Ratio Rank
NDAQ
NDAQ Risk / Return Rank: 4848
Overall Rank
NDAQ Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
NDAQ Sortino Ratio Rank: 4343
Sortino Ratio Rank
NDAQ Omega Ratio Rank: 4444
Omega Ratio Rank
NDAQ Calmar Ratio Rank: 5050
Calmar Ratio Rank
NDAQ Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2B70.DE vs. NDAQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Nasdaq, Inc. (NDAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

2B70.DENDAQDifference
Sharpe ratioReturn per unit of total volatility
2.04
0.20

+1.84

Sortino ratioReturn per unit of downside risk
2.89
0.42

+2.47

Omega ratioGain probability vs. loss probability

1.34

1.06

+0.28

Calmar ratioReturn relative to maximum drawdown

6.15

0.21

+5.94

Martin ratioReturn relative to average drawdown

17.06

0.50

+16.56

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

2B70.DE vs. NDAQ - Sharpe Ratio Comparison

The current 2B70.DE Sharpe Ratio is 2.04, which is higher than the NDAQ Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of 2B70.DE and NDAQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

2B70.DENDAQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.04

0.20

+1.84

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.28

0.49

-0.21

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.68

—

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.43

-0.08

Drawdowns

2B70.DE vs. NDAQ - Drawdown Comparison

The maximum 2B70.DE drawdown since its inception was -30.87%, smaller than the maximum NDAQ drawdown of -64.79%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and NDAQ.

Loading charts...

Drawdown Indicators

2B70.DENDAQDifference

Max Drawdown

Largest peak-to-trough decline

-30.87%

-64.79%

+33.92%

Max Drawdown (1Y)

Largest decline over 1 year

-6.33%

-23.55%

+17.22%

Max Drawdown (3Y)

Largest decline over 3 years

-29.34%

-24.62%

-4.72%

Max Drawdown (5Y)

Largest decline over 5 years

-30.87%

-31.49%

+0.62%

Max Drawdown (10Y)

Largest decline over 10 years

—

-36.46%

—

Current Drawdown

Current decline from peak

-1.26%

-12.24%

+10.98%

Average Drawdown

Average peak-to-trough decline

-10.01%

-19.57%

+9.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.29%

9.94%

-7.65%

Volatility

2B70.DE vs. NDAQ - Volatility Comparison

The current volatility for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) is 6.65%, while Nasdaq, Inc. (NDAQ) has a volatility of 7.27%. This indicates that 2B70.DE experiences smaller price fluctuations and is considered to be less risky than NDAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

2B70.DENDAQDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.65%

7.27%

-0.62%

Volatility (6M)

Calculated over the trailing 6-month period

14.26%

21.00%

-6.74%

Volatility (1Y)

Calculated over the trailing 1-year period

19.09%

25.26%

-6.17%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.34%

24.25%

-3.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.76%

24.77%

-3.01%

Dividends

2B70.DE vs. NDAQ - Dividend Comparison

2B70.DE has not paid dividends to shareholders, while NDAQ's dividend yield for the trailing twelve months is around 1.22%.

PositionTTM20252024202320222021202020192018201720162015
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NDAQ
Nasdaq, Inc.		1.22%1.08%1.22%1.48%1.27%1.00%1.46%1.73%2.08%1.90%1.80%1.55%

Frequently Asked Questions

2B70.DE and NDAQ have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for 2B70.DE and NDAQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer